CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Krystal Biotech joins the S&P MidCap 400 as TMHC and AVNS exit indexes

Positive
AI Analysis

Summary

Krystal Biotech has been added to the S&P MidCap 400 index as TMHC and AVNS exit the index.

Importance:3/10
Sentiment:
0.50
index inclusionS&P MidCap 400market capitalization
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 20, 2026 10:06 PM

Read Original